Vietnam In Vitro Diagnostics Market Size, Share, Trends, Demand And Forecast 2025-2033

Base Year: 2024

Historical Years: 2019-2024

Forecast Years: 2025-2033

Market Size in 2024: USD 335.3 Million

Market Forecast in 2033:USD 494.4 Million

Market Growth Rate (2025-33): 4.19%

Vietnam in vitro diagnostics market size reached USD 335.3 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 494.4 Million by 2033, exhibiting a growth rate (CAGR) of 4.19% during 2025-2033. The rising healthcare awareness, rapidly aging population across the region, favorable government initiatives, increasing prevalence of chronic and infectious diseases, significant technological advancements, growing medical tourism, represent some of the key factors driving the market.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/vietnam-in-vitro-diagnostics-market/requestsample

Vietnam In Vitro Diagnostics Market Trends and Drivers:

Vietnam's IVD market is experiencing robust growth fundamentally anchored in the persistent high burden of infectious diseases and the government's amplified commitment to proactive screening. While COVID-19 catalyzed significant testing infrastructure investment and public awareness, the focus has strategically broadened. Endemic challenges like dengue fever (with over 300,000 suspected cases annually requiring rapid NS1 antigen and serology testing), hepatitis B (affecting an estimated 8-10% of the population, demanding widespread screening and viral load monitoring), and tuberculosis drive consistent demand for reliable serological, molecular (PCR), and rapid diagnostic tests (RDTs). Concurrently, national screening initiatives are expanding beyond infectious diseases. Significant investments target non-communicable diseases (NCDs), particularly early cancer detection (cervical, breast, liver) utilizing advanced cytology, immunohistochemistry (IHC), and tumor marker assays, alongside prenatal screening programs employing immunoassays for biomarkers like PAPP-A and free beta-hCG. This dual focus – managing established infectious threats while aggressively tackling NCDs through early diagnosis – creates a sustained, multi-faceted demand driver across various IVD segments, from basic lateral flow devices to sophisticated molecular platforms, ensuring long-term market expansion and necessitating continuous laboratory capacity building and test menu diversification.

The accelerating prevalence of chronic diseases, particularly diabetes and cardiovascular disease (CVD), represents a transformative dynamic reshaping Vietnam's IVD market towards sophisticated, continuous monitoring solutions. Driven by rapid urbanization, dietary shifts, sedentary lifestyles, and an aging population, diabetes prevalence now exceeds 7% of adults, while hypertension affects nearly one-quarter. This epidemic necessitates a paradigm shift beyond initial diagnosis to encompass ongoing management, driving exponential growth in point-of-care testing (POCT) for HbA1c (critical for glycemic control monitoring) and lipid panels, alongside high-sensitivity cardiac troponin (hs-cTn) assays for rapid acute coronary syndrome (ACS) rule-out in emergency settings. The demand extends to advanced laboratory-based tests like NT-proBNP for heart failure management and apolipoprotein testing for refined cardiovascular risk stratification. This trend compels investments in higher-throughput automated chemistry and immunoassay analyzers for central labs, while simultaneously fueling the decentralization of diagnostics through CLIA-waived devices in clinics and pharmacies. The focus is shifting towards integrated chronic disease management pathways, where IVD plays a central role in treatment adjustment and complication prevention, creating recurring revenue streams through reagents and consumables and demanding connectivity solutions (LIS/HIS integration) for seamless data flow.

A powerful dynamic is the rapid decentralization of diagnostics, propelled by technological innovation, government policy favoring universal healthcare access, and the need for faster clinical decision-making, particularly outside major urban centers. The POCT segment is the fastest-growing within Vietnam's IVD market, driven by the proliferation of compact, user-friendly, and increasingly sophisticated devices – from glucometers and HbA1c analyzers to rapid flu/COVID combo tests, cardiac marker testers, and even basic hematology and coagulation monitors. Key drivers include the Ministry of Health's push to strengthen primary healthcare infrastructure at commune and district levels, the burgeoning private clinic and pharmacy chains expanding diagnostic services, and the demand for near-patient testing in hospital emergency departments and ICUs to reduce turnaround times (TAT). Technological advancements in microfluidics, biosensors, and connectivity (enabling remote quality control and electronic result reporting) are making POCT more reliable and integrated. This decentralization addresses critical gaps in rural healthcare access, reduces the burden on overloaded central labs in cities like Hanoi and Ho Chi Minh City, and empowers clinicians with immediate results for time-sensitive conditions (e.g., troponin for heart attacks, CRP for infection). However, it necessitates robust training programs, stringent quality management systems, and clear regulatory frameworks for device approval and operator competency, presenting both immense opportunities and challenges for IVD manufacturers and healthcare providers alike.

Vietnam In Vitro Diagnostics Market Industry Segmentation:

Product & Service Insights:

• Reagents
• Instruments
• Software and Services

Technique Insights:

• Immunodiagnostics
• Hematology
• Molecular Diagnostics
• Tissue Diagnostics
• Clinical Chemistry
• Others

Application Insights:

• Infectious Disease
• Cancer
• Cardiac Disease
• Immune System Disease
• Nephrological Disease
• Others

End User Insights:

• Hospitals and Clinics
• Diagnostics Laboratories
• Others

Regional Insights:

• Northern Vietnam
• Central Vietnam
• Southern Vietnam

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players.

Key highlights of the Report:

• Market Performance (2019-2024)
• Market Outlook (2025-2033)
• COVID-19 Impact on the Market
• Porter's Five Forces Analysis
• Strategic Recommendations
• Historical, Current and Future Market Trends
• Market Drivers and Success Factors
• SWOT Analysis
• Structure of the Market
• Value Chain Analysis
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world's most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email:

Tel No:(D) +91 120 433 0800

United States: +1-201971-6302

MENAFN29072025004122016232ID1109856073